{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:53:55Z","timestamp":1774619635839,"version":"3.50.1"},"reference-count":41,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T00:00:00Z","timestamp":1713052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Hypertensive disorders of pregnancy (HDPs) represent a significant source of severe maternal and fetal morbidity. Screening strategies relying on traditional medical history and clinical risk factors have traditionally shown relatively modest performance, mainly in the prediction of preeclampsia, displaying a sensitivity of 37% for the early-onset form and 29% for the late-onset form. The development of more accurate predictive and diagnostic models of preeclampsia in the early stages of pregnancy represents a matter of high priority. The aim of the present paper is to create an effective second trimester prediction algorithm of early-onset HDP occurrence and severity, by combining the following two biochemical markers: a soluble fms-like tyrosine kinase 1 (sFlt-1)\/placental growth factor (PlGF) ratio and uterine artery Doppler ultrasound parameters, namely the pulsatility index (PI) and the resistivity index (RI), in a population of high-risk pregnant women, initially assessed through traditional risk factors. A prospective single-center observational longitudinal study was conducted, in which 100 women with singleton pregnancy and traditional clinical and medical history risk factors for preeclampsia were enrolled at 24 weeks of gestation. Shortly after study enrollment, all women had their sFlt-1 and PlGF levels and mean uterine artery PI and RI determined. All pregnancies were followed up until delivery. Receiver operating characteristic (ROC) analysis established algorithms based on cutoffs for the prediction of the later development of preeclampsia: PI 1.25 (96.15% sensitivity, 86.49% specificity), RI 0.62 (84.6% sensitivity, 89.2% specificity) and sFlt-1\/PlGF ratio 59.55 (100% sensitivity, 89.2% specificity). The sFlt-1\/PlGF ratio was the best predictor for preeclampsia, as it displayed the highest area under the curve (AUC) of 0.973. The prediction algorithm for the severe form of preeclampsia, complicated by fetal growth restriction leading to preterm birth, antepartum fetal demise or acute fetal distress with a cerebro-placental ratio of &lt;one consisted of the following cutoffs: PI 1.44 (93.75% sensitivity, 95.24% specificity), RI 0.69 (87.5% sensitivity, 100% specificity) and sFlt-1\/PlGF ratio 102.74 (93.75% sensitivity, 95.2% specificity). These algorithms may significantly enhance the prediction accuracy of preeclampsia compared to traditional risk factors. The combination of the sFlt-1\/PlGF ratio with mean uterine PI and RI in particular displayed an improved performance in the prediction of severe preeclampsia with the above-mentioned complications, compared to the biochemical markers or uterine Doppler parameters used alone. Therefore, HDP screening strategies should increasingly focus on implementing such algorithms for women who are initially regarded as high risk based on traditional risk factors, in order to properly diagnose HDP and properly limit or manage the later maternal and fetal complications.<\/jats:p>","DOI":"10.3390\/children11040468","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T11:53:53Z","timestamp":1713182033000},"page":"468","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Second Trimester Prediction Algorithm for Early-Onset Hypertensive Disorders of Pregnancy Occurrence and Severity Based on Soluble fms-like Tyrosine Kinase 1 (sFlt-1)\/Placental Growth Factor (PlGF) Ratio and Uterine Doppler Ultrasound in Women at Risk"],"prefix":"10.3390","volume":"11","author":[{"given":"Cristian Nicolae","family":"Chiril\u0103","sequence":"first","affiliation":[{"name":"Department of Internal Medicine-Nephrology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u0219, 540142 T\u00e2rgu Mure\u0219, Romania"},{"name":"Department of Nephrology, Mures Clinical County Hospital, 540103 T\u00e2rgu Mure\u0219, Romania"},{"name":"Doctoral School, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u0219, 540142 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu","family":"M\u0103rginean","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology 2, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u0219, 540142 T\u00e2rgu Mure\u0219, Romania"},{"name":"Department of Obstetrics and Gynecology, Mures Clinical County Hospital, 540057 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana Valentina","family":"Ghiga","sequence":"additional","affiliation":[{"name":"Department of Scientific Medical Research Methodology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u0219, 540142 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Septimiu","family":"Void\u0103zan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u0219, 540142 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Maria","family":"Chiril\u0103","sequence":"additional","affiliation":[{"name":"Doctoral School, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u0219, 540142 T\u00e2rgu Mure\u0219, Romania"},{"name":"Department of Endocrinology, Mures Clinical County Hospital, 540142 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirela Liana","family":"Gliga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine-Nephrology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of T\u00e2rgu Mure\u0219, 540142 T\u00e2rgu Mure\u0219, Romania"},{"name":"Department of Nephrology, Mures Clinical County Hospital, 540103 T\u00e2rgu Mure\u0219, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"key":"ref_2","first-page":"e31143","article-title":"Preeclampsia Incidence and Its Maternal and Neonatal Outcomes With Associated Risk Factors","volume":"14","author":"Khan","year":"2022","journal-title":"Cureus"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","author":"Espinoza","year":"2020","journal-title":"Obstet Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"785219","DOI":"10.3389\/fphys.2021.785219","article-title":"Assessing the Role of Uric Acid as a Predictor of Preeclampsia","volume":"12","author":"Corominas","year":"2022","journal-title":"Front. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/HJH.0000000000003472","article-title":"Serum uric acid to creatinine ratio and risk of preeclampsia and adverse pregnancy outcomes","volume":"41","author":"Piani","year":"2023","journal-title":"J. Hypertens."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Chiril\u0103, C.N., M\u0103rginean, C., Chiril\u0103, P.M., and Gliga, M.L. (2023). The Current Role of the sFlt-1\/PlGF Ratio and the Uterine-Umbilical-Cerebral Doppler Ultrasound in Predicting and Monitoring Hypertensive Disorders of Pregnancy: An Update with a Review of the Literature. Children, 10.","DOI":"10.3390\/children10091430"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2014.09.027","article-title":"Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: A meta-analysis","volume":"182","author":"Allen","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_10","first-page":"117","article-title":"Soluble FMS-like tyrosine kinase 1: An overview","volume":"6","author":"Selvarajan","year":"2023","journal-title":"Int. J. Med. Biochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.2174\/1381612827666210902155015","article-title":"sFlt-1: A Double Regulator in Angiogenesis-related Diseases","volume":"27","author":"Liao","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/jhh.2017.61","article-title":"Placental growth factor and pre-eclampsia","volume":"31","author":"Chau","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/uog.26032","article-title":"Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction","volume":"61","author":"Stepan","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_15","unstructured":"Magley, M., and Hinson, M.R. (2023). StatPearls [Internet], StatPearls Publishing."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/uog.20105","article-title":"ISUOG Practice Guidelines: Role of ultrasound in screening for and follow-up of preeclampsia","volume":"53","author":"Sotiriadis","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1080\/14767058.2018.1481953","article-title":"Combined Doppler ultrasound and platelet indices for prediction of preeclampsia in high-risk pregnancies","volume":"32","author":"Mostafa","year":"2019","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"275613","DOI":"10.1155\/2009\/275613","article-title":"Maternal history and uterine artery Doppler in the assessment of risk for development of early- and late-onset preeclampsia and intrauterine growth restriction","volume":"2009","author":"Llurba","year":"2009","journal-title":"Obstet. Gynecol. Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0040-1712124","article-title":"Screening for Preeclampsia in the First Trimester and Aspirin Prophylaxis: Our First Year","volume":"42","author":"Gomes","year":"2020","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/uog.22134","article-title":"ISUOG Practice Guidelines: Diagnosis and management of small-for-gestational-age fetus and fetal growth restriction","volume":"56","author":"Lees","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/uog.26092","article-title":"Reference ranges of uterine artery pulsatility index from first to third trimester based on serial Doppler measurements: Longitudinal cohort study","volume":"61","author":"Cavoretto","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00404-011-1960-4","article-title":"Serum PlGF as a potential biomarker for predicting the onset of preeclampsia","volume":"285","author":"Ghosh","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","article-title":"Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia: INSPIRE","volume":"74","author":"Cerdeira","year":"2019","journal-title":"Hypertension"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Eng. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ajog.2020.11.007","article-title":"Performance of soluble fms-like tyrosine kinase-1-to-placental growth factor ratio of \u226585 for ruling in preeclampsia within 4\u2009weeks","volume":"224","author":"Cerdeira","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3343\/alm.2018.38.2.95","article-title":"Evaluation of sFlt-1\/PlGF ratio for Predicting and Improving Clinical Management of Preeclampsia: Experience in a Specialized Perinatal Care Center","volume":"38","author":"Caillon","year":"2018","journal-title":"Ann. Lab. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","article-title":"Short-term prediction of adverse outcomes using the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor) ratio in Asian women with suspected preeclampsia","volume":"74","author":"Bian","year":"2019","journal-title":"Hypertension"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/jog.14815","article-title":"sFlt-1\/PlGF ratio as a predictive and prognostic marker for preeclampsia","volume":"47","author":"Jeon","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2020.11.010","article-title":"Real life outpatient biomarker use in management of hypertensive pregnancies in third trimester in a low resource Setting: ROBUST study","volume":"23","author":"Soundararajan","year":"2021","journal-title":"Pregnancy Hypertens."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ciciu, E., Pa\u1e63atu-Cornea, A.M., Dumitru, S., Petcu, L.C., Salim, C., and Tuta, L.A. (2023). Utility of sFtl-1 and Placental Growth Factor Ratio for Adequate Preeclampsia Management. Healthcare, 11.","DOI":"10.3390\/healthcare11030381"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cca.2022.01.021","article-title":"The clinical value of PlGF and the sFlt1\/PlGF ratio in the management of hypertensive pregnancy disorders: A retrospective real-world study in China","volume":"528","author":"Yang","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/npmj.npmj_161_18","article-title":"Uterine and umbilical artery doppler in women with pre-eclampsia and their pregnancy outcomes","volume":"26","author":"Adekanmi","year":"2019","journal-title":"Niger. Postgrad. Med. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"368504211036856","DOI":"10.1177\/00368504211036856","article-title":"Prediction of preeclampsia using a combination of serum micro RNA-210 and uterine artery Doppler ultrasound","volume":"104","author":"Trongpisutsak","year":"2021","journal-title":"Sci. Prog."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.21873\/invivo.11722","article-title":"Doppler Indices and Notching Assessment of Uterine Artery Between the 19th and 22nd Week of Pregnancy in the Prediction of Pregnancy Outcome","volume":"33","author":"Ratiu","year":"2019","journal-title":"In Vivo"},{"key":"ref_36","first-page":"515","article-title":"Diagnostic evaluation of uterine artery Doppler sonography for the prediction of adverse pregnancy outcomes","volume":"19","author":"Barati","year":"2014","journal-title":"J. Res. Med. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00404-017-4457-y","article-title":"Maternal serum homocysteine and uterine artery Doppler as predictors of preeclampsia and poor placentation","volume":"296","author":"Maged","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ijgo.14435","article-title":"Abnormal uterine artery Doppler ultrasound during gestational 21-23\u2009weeks associated with pre-eclampsia","volume":"161","author":"Li","year":"2023","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1080\/14767058.2016.1183631","article-title":"First trimester uterine artery Doppler, sFlt-1 and PlGF to predict preeclampsia in a high-risk population","volume":"30","author":"Diguisto","year":"2017","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00404-019-05365-9","article-title":"Role of sFlt-1\/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia","volume":"301","author":"Graupner","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Oancea, M., Grigore, M., Ciortea, R., Diculescu, D., Bodean, D., Bucuri, C., Strilciuc, S., Rada, M., and Mihu, D. (2020). Uterine Artery Doppler Ultrasonography for First Trimester Prediction of Preeclampsia in Individuals at Risk from Low-Resource Settings. Medicina, 56.","DOI":"10.3390\/medicina56090428"}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/11\/4\/468\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:27:55Z","timestamp":1760106475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/11\/4\/468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,14]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["children11040468"],"URL":"https:\/\/doi.org\/10.3390\/children11040468","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,14]]}}}